# EDGAR Filing Document

**Accession Number:** 0001737927
**File Stem:** 0001193125-23-081459
**Filing Date:** 2023-3
**Character Count:** 17419
**Document Hash:** 7a8d0af627338388e0d20b55d0a47e0b
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-081459.hdr.sgml**: 20230328

**ACCESSION NUMBER**: 0001193125-23-081459

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 15

**CONFORMED PERIOD OF REPORT**: 20230324

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230328

**DATE AS OF CHANGE**: 20230328

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Canopy Growth Corp
- **CENTRAL INDEX KEY:** 0001737927
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** Z4
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-38496
- **FILM NUMBER:** 23766265

**BUSINESS ADDRESS:**
- **STREET 1:** 1 HERSHEY DRIVE
- **CITY:** SMITH FALLS
- **STATE:** A6
- **ZIP:** K7A0A8
- **BUSINESS PHONE:** 855-558-9333

**MAIL ADDRESS:**
- **STREET 1:** 1 HERSHEY DRIVE
- **CITY:** SMITH FALLS
- **STATE:** A6
- **ZIP:** K7A0A8

?xml version="1.0" encoding="utf-8" ? 8-K

------

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

------

### FORM 8-K

------

#### CURRENT REPORT

#### PURSUANT TO SECTION 13 OR 15(d)

#### OF THE SECURITIES EXCHANGE ACT OF 1934

#### Date of Report (Date of earliest event reported): March 24, 2023

------

## Canopy Growth Corporation

#### (Exact name of registrant as specified in its charter)

------

---

| | | |
|:---|:---|:---|
| **Canada** | **001-38496** | **N/A** |
| **(State or other jurisdiction**<br> **of incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **1 Hershey Drive<br>Smiths Falls, Ontario** | **K7A 0A8** |
| **(Address of principal executive officers)** | **(Zip Code)** |

---

(855) 558-9333

#### (Registrant's telephone number, including area code)

#### Not Applicable

#### (Former name or former address, if changed since last report)

------

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading<br>Symbol(s)** | **Name of each exchange**<br> **on which registered** |
| Common Shares, no par value | CGC | NASDAQ Global Select Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 8.01** | **Other Events.**  |

---

On March 24, 2023, Canopy Growth Corporation (the "Company") received a decision from an arbitration tribunal (the "Tribunal") in connection with a dispute arising from the services rendered pursuant to a services agreement involving the Company (the "Services Agreement") and the Company's subsequent termination of the Services Agreement. The Tribunal held that the Company did not have the right to terminate the Services Agreement. As a result, the Tribunal awarded the counterparty: (i) default damages in the amount of approximately C$15 million, inclusive of taxes; (ii) pre-award and post-award interest at the annual rate of 5.5%, compounded monthly, from December 9, 2021 to the date of payment of paragraph (i); and (iii) the costs of the counterparties to the arbitration in an amount to be fixed by the Tribunal. The Company continues to consider all options that may be available to it with respect to the Tribunal's decision.

On March 28, 2023, the Company filed with the Securities and Exchange Commission (the "SEC") a prospectus supplement dated March 28, 2023 (the "Prospectus Supplement") to its prospectus dated March 31, 2021, which was filed with the SEC on March 31, 2021 and amended and restated the Company's base prospectus, dated February 23, 2021, which was included in its automatic shelf registration statement on Form S-3 (File No. 333-253399) (the "Registration Statement") filed with the SEC on February 23, 2021. The Prospectus Supplement relates to the resale from time to time by certain selling securityholders of an aggregate of 7,102,081 common shares (the "Shares") of the Company.

In connection with the resale registration of the Shares, the Company is filing as Exhibit 5.1 hereto the opinion of its counsel, Cassels Brock & Blackwell LLP, regarding the legality of the Shares. Exhibit 5.1 is incorporated herein by reference and into the Registration Statement and the Prospectus Supplement.

---

| | |
|:---|:---|
| **Item 9.01** | **Financial Statements and Exhibits.**  |

---

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit**<br>**No.** | **Description** |
| &nbsp;&nbsp;&nbsp;&nbsp;5.1 | [Opinion of Cassels Brock & Blackwell LLP regarding the legality of the shares offered](d452841dex51.htm) |
| 23.1 | [Consent of Cassels Brock & Blackwell LLP (included in Exhibit 5.1)](d452841dex51.htm) |
| 104 | Cover Page Interactive Data File—the cover page XBRL tags are embedded within the Inline XBRL document. |

---

------

#### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| **CANOPY GROWTH CORPORATION** | **CANOPY GROWTH CORPORATION** |
| By: | /s/ Judy Hong |
|  | Judy Hong |
|  | Chief Financial Officer |

---

Date: March 28, 2023

## Exhibit 5.1

**Exhibit 5.1**![LOGO](g452841dsp1.jpg)

March 28, 2023

Canopy Growth Corporation

1 Hershy Drive

Smiths Falls, Ontario

K7A 0A8 Canada

Dear Sirs/Mesdames:

---

| | |
|:---|:---|
| **Re:** | **Registration Statement on Form S-3 (File No. 333-253399)**  |

---

------

We have acted as counsel to Canopy Growth Corporation, a corporation incorporated under the federal laws of Canada (the "**Company**"), in connection with certain matters of law relating to the registration by the Company, under the U.S. Securities Act of 1933, as amended (the "**Securities Act**"), of an aggregate of 7,102,081 common shares in the capital of the Company (the "**Shares**"), covered by the Company's registration statement on Form S-3 (File No. 333-253399) (the "**Registration Statement**") filed with the U.S. Securities and Exchange Commission (the "**Commission**") on February 23, 2021. The Shares were issued on March 17, 2023, pursuant to the TRA Agreement (as defined below). This opinion letter is being furnished in accordance with the requirements of Item 601 of Regulation S-K under the Securities Act.

**1.** **EXAMINATIONS AND INVESTIGATIONS** 

*Documents.* We have examined and relied upon originals or copies, certified or otherwise identified to our satisfaction, of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) a certificate of compliance (the "**Certificate of Compliance**") dated March 27, 2023 issued
for the Company under the *Canada Business Corporations Act* (the "**CBCA** "), a copy of which we have delivered to you;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the articles of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the by-laws of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) certain resolutions of the Company's board of directors relating to the issuance of the Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) a certificate, dated the date of this opinion, of an officer of the Company (the "**Officer's Certificate** "), including copies of each of the items in paragraphs (b), (c), and (d) above, a copy of which we have delivered to you;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) the third amendment to tax receivable agreement dated October 24, 2022 among the Company, Canopy USA, LLC
(" **Canopy USA** "), Acreage Holdings America, Inc., High Street Capital Partners, LLC ()"**HSCP**") and certain members of HSCP party thereto (the "**TRA Agreement** ");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) the share issuance agreement dated October 24, 2022 between 11065220 Canada Inc.
(" **11065220** "), a wholly owned subsidiary of the Company and Canopy USA (the "**11065220 Agreement** ");

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) the share issuance agreement dated March 17, 2023 between the Company and 11065220 (together with the TRA
Agreement and the 11065220 Agreement, the "**Transaction Documents** "); and

------

![LOGO](g452841dsp1a.jpg)

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the Registration Statement and the related prospectus supplement thereto, dated March 28, 2023 (the
" **Prospectus Supplement** "), filed with the Commission pursuant to Rule 424(b)(7) under the Securities Act.

*Minute Books*. Except for the corporate records forming part of the Officer's Certificate and such other corporate records as we deemed necessary, we have not reviewed the minute books of the Company.

**2.** **ASSUMPTIONS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Authenticity*. We have assumed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the legal capacity of all individuals signing documents,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the genuineness of all signatures,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) the authenticity and completeness of all documents submitted to us as originals,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) the conformity to authentic original documents of all documents submitted to us as copies, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) the continuing accuracy of the Certificate of Compliance as of the date of this opinion as if issued on that
date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Enforceability, etc., of Transaction Documents executed by others*. We have assumed that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) each party to each Transaction Document other than the Company:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) is existing under the laws of its jurisdiction of formation, as applicable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) has the requisite power and capacity to carry on business, own properties and assets, and execute, deliver, and
perform its obligations under that Transaction Document and to carry out the transactions contemplated under that Transaction Document;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C) has taken all necessary action to authorize the execution and delivery of, and the performance of its
obligations under, that Transaction Document; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D) has duly executed and delivered that Transaction Document;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) the exercise, by each party other than the Company, of its rights and the performance of its obligations under
each Transaction Document is not contrary to its constating documents or governing legislation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) each Transaction Document constitutes a legal, valid, and binding obligation of each party to it other than the
Company, enforceable against that party in accordance with its terms;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) the representations and warranties of each party to each Transaction Document other than the Company are true
and correct and accurate in all respects; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) to the extent that any of the Transaction Documents are to be performed in any jurisdiction other than the
Provinces (as defined below), such performance will not be illegal under the laws of that jurisdiction.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) *Public records*. We have assumed the completeness, accuracy, and currency of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) the indices and filing systems maintained at the public offices where we searched or made inquiries,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) all documents supplied or otherwise conveyed to us by public officials, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) all facts set out in those documents and in official public records.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) *Trading restrictions*. We have assumed that, at the time of any distribution of or trade in securities of
the Company referred to in this opinion, no order, ruling, or decision granted by a securities commission, court of competent jurisdiction, or regulatory or administrative body having jurisdiction is in effect that would:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) restrict any distribution of or trade in those securities, or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) affect any person or company who engaged in any such distribution or trade (including, without limitation, any
cease trade orders).

**3.** **RELIANCE** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) *Matters of fact in the Officer's Certificates*. We have relied solely upon the Officer's
Certificate as to the matters of fact set out in such certificate, without independently verifying those facts.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) *Company Status*. In expressing the opinion in section 5(a), we have relied and our opinion is based
solely upon the Certificate of Compliance and the Officer's Certificate.

**4.** **LAWS ADDRESSED** 

The opinions we express are limited to the laws of the Provinces of Ontario, British Columbia and Alberta (together, the "**Provinces**") and the federal laws of Canada applicable in the Provinces. For the purposes of this opinion, the term "**Securities Laws**" means the *Securities Act* (Ontario), together with the regulations and rules made under that act, the *Securities Act* (British Columbia), together with the regulations, rules, and forms made under that act and the blanket rulings and orders issued by the British Columbia Securities Commission and the *Securities Act* (Alberta), together with the regulations and rules under that act and the blanket rulings and orders issued by the Alberta Securities Commission.

We are solicitors qualified to carry on the practice of law in the Provinces only, and we express no opinion as to any laws, or matters governed by any laws, other than the laws of the Provinces and the federal laws of Canada applicable therein. The opinions herein are limited to the laws of the Provinces and the federal laws of Canada applicable therein in effect as of the date hereof and we assume no obligation to update these opinions to take into account any changes in such laws after the date hereof.

**5.** **OPINIONS** 

Based upon and subject to the foregoing and subject to the qualifications expressed below, we are of the opinion that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The Company is a corporation existing under the CBCA.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The issuance of the Shares has been duly authorized and the Shares are validly issued as fully-paid and non-assessable common shares in the capital of the Company.

------

**6.** **USE OF OPINION** 

This opinion letter is rendered solely in connection with the registration of the Shares for resale by the selling shareholders set forth in the Prospectus Supplement.

We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Company's Current Report on Form 8-K to be filed with the Commission on or about March 28, 2023, which will be incorporated by reference in the Registration Statement, and to the reference to our firm under the heading "Legal Matters" in the Prospectus Supplement, which is a part of the Registration Statement. In giving such consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules or regulations of the Commission thereunder.

Yours truly,

*CASSELS BROCK & BLACKWELL LLP*